24 results on '"Cohen, Stanley"'
Search Results
2. A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.
3. Mo1581 THE IMPACT OF OBESITY ON HOSPITAL-RELATED OUTCOMES IN PATIENTS WHO UNDERGO LIVER TRANSPLANTATION: A NATIONWIDE ANALYSIS.
4. Colon capsule endoscopy compared with other modalities in the evaluation of pediatric Crohn’s disease of the small bowel and colon.
5. Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota.
6. Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate Combination.
7. Capsule endoscopy followed by single balloon enteroscopy in children with obscure gastrointestinal bleeding: A combined approach.
8. Capsule endoscopy in pediatrics: A growing experience.
9. Su1369: CORRELATION BETWEEN LIVER ELASTOGRAPHY, FIB-4, AND LIVER BIOPSIES IN TERTIARY TRANSPLANT REFERRAL CENTER IN THE USA.
10. Dyspnea in Hepatocellular Carcinoma.
11. Su497 PHARMACOKINETICS (PK), SAFETY, AND EFFICACY OF INTRAVENOUS (IV) VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE: RESULTS FROM THE PHASE 2 HUBBLE STUDY.
12. Sa581 FEASIBILITY OF USING REAL-WORLD DATA FROM THE IMPROVECARENOW REGISTRY TO EXAMINE THE EFFICACY OF USTEKINUMAB FOR PEDIATRIC CROHN'S DISEASE.
13. Sa469 PERFORMANCE OF THE SHORT PEDIATRIC CROHN'S DISEASE ACTIVITY INDEX (SPCDAI) AS A CLINICAL EFFECTIVENESS ENDPOINT.
14. 180 CLINICAL CHARACTERISTICS, CLINICAL RESPONSE, AND CLINICAL REMISSION STATUS IN ADULTS TREATED WITH USTEKINUMAB IN THE PHASE 3 UNITI STUDIES AT WEEK 6 AND WEEK 44 BY AGE AT CROHN'S DISEASE ONSET.
15. 288 PAN-ENTERIC CAPSULE ENDOSCOPY IN PEDIATRIC CROHN'S DISEASE – THE PED-PAN STUDY: PRELIMINARY RESULTS OF A MULTICENTER TRIAL.
16. Clinical Characteristics, Hospitalization, and Mortality Rates of Coronavirus Disease 2019 Among Liver Transplant Patients in the United States: A Multicenter Research Network Study.
17. Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection.
18. A Treat to Target Strategy Using Panenteric Capsule Endoscopy in Pediatric Patients With Crohn's Disease.
19. Sa2069 A Prospective 52-Week Mucosal Healing and Deep Remission Assessment of Small Bowel and Colonic Crohn's Disease as Detected by Colon Capsule Endoscopy.
20. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
21. 705 A Prospective 24-Week Mucosal Healing and Deep Remission Assessment of Small Bowel and Colonic Crohn Disease as Detected by Colon Capsule Endoscopy.
22. 851 Colon Capsule Endoscopy Compared to Other Modalities in the Evaluation of Small Bowel and Colonic Pediatric Crohn's Disease.
23. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease.
24. THU-198-Efficacy and safety of glecaprevir/pibrentasvir treatment for 8 weeks in treatment-naive patients with chronic hepatitis C virus infection without cirrhosis or with compensated cirrhosis: Analysis of data pooled from phase 2 and 3 studies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.